U
Better Therapeutics, Inc. BTTX
$0.0002 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 19.10M 21.11M 21.69M 21.82M 22.30M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 29.61M 35.27M 37.84M 38.26M 42.04M
Operating Income -29.61M -35.27M -37.84M -38.26M -42.04M
Income Before Tax -31.56M -37.11M -39.45M -39.75M -44.89M
Income Tax Expenses 9.00K 9.00K 8.00K 7.00K 0.00
Earnings from Continuing Operations -31.57 -37.12 -39.46 -39.76 -44.89
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -31.57M -37.12M -39.46M -39.76M -44.89M
EBIT -29.61M -35.27M -37.84M -38.26M -42.04M
EBITDA -27.21M -33.01M -35.73M -36.24M -40.01M
EPS Basic -1.16 -1.49 -1.66 -1.68 -1.96
Normalized Basic EPS -0.72 -0.93 -1.04 -1.05 -1.26
EPS Diluted -1.16 -1.49 -1.66 -1.68 -1.96
Normalized Diluted EPS -0.72 -0.93 -1.04 -1.05 -1.26
Average Basic Shares Outstanding 117.28M 102.48M 94.86M 94.45M 90.39M
Average Diluted Shares Outstanding 117.28M 102.48M 94.86M 94.45M 90.39M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings